本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Revolution Medicines, Inc.

52.98
-0.5100-0.95%
盘后52.980.00000.00%17:22 EDT
成交量:185.25万
成交额:9,853.24万
市值:99.04亿
市盈率:-11.71
高:54.49
开:53.50
低:52.62
收:53.49
52周最高:62.40
52周最低:29.17
股本:1.87亿
流通股本:1.59亿
量比:0.75
换手率:1.17%
股息:- -
股息率:- -
每股收益(TTM):-4.5252
每股收益(LYR):-3.5776
净资产收益率:-46.61%
总资产收益率:-26.47%
市净率:5.31
市盈率(LYR):-14.81

数据加载中...

2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/23

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2023/11/01

重要事件披露

Form 8-K - Current report